This is in line with a previous study showing beneficial effects of another competitive S1P1 antagonist (TASP0277308) in a mouse arthritis model, with reduction of T cell infiltration into the joints and modulation of local cytokine production [12]. Here, S1PR1 is linked to arthritic joint disease.